PMID- 38073770
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231211
IS  - 1792-1082 (Electronic)
IS  - 1792-1074 (Print)
IS  - 1792-1074 (Linking)
VI  - 27
IP  - 1
DP  - 2024 Jan
TI  - Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 
      gene fusion: A case report and literature review.
PG  - 29
LID - 10.3892/ol.2023.14162 [doi]
LID - 29
AB  - Renal cell carcinoma (RCC) associated with Xp11.2 translocation/transcription 
      factor E3 (TFE3) gene fusion is a rare subtype of RCC. A 31-year-old male patient 
      was admitted to The Affiliated Hospital of Zunyi Medical University (Zunyi, 
      China) with a solid mass in the left kidney during a routine health examination. 
      After ruling out surgical contraindications, the patient underwent a laparoscopic 
      left partial nephrectomy under general anesthesia. Postoperative pathology and 
      fluorescence in situ hybridization (FISH) identified Xp11.2 translocation RCC. 
      There was no tumor recurrence or metastasis during the 1-year follow-up. Xp11.2 
      translocation RCC is unusual, its clinical and imaging findings are not specific, 
      and the diagnosis depends on TFE3-immunohistochemical assay and FISH analysis. 
      Surgical resection is the first choice of treatment and its prognosis is worse 
      than that of clear cell RCC, thus regular follow-ups are necessary.
CI  - Copyright: (c) Yang et al.
FAU - Yang, Denghao
AU  - Yang D
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Tang, Wen
AU  - Tang W
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Liu, Mingwen
AU  - Liu M
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Xie, Zhifei
AU  - Xie Z
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Shi, Fei
AU  - Shi F
AD  - Department of Urology, People's Hospital of Honghuagang District, Zunyi, Guizhou 
      563000, P.R. China.
FAU - Zhao, Zeju
AU  - Zhao Z
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Yang, Xiaorong
AU  - Yang X
AD  - Department of Pathology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
FAU - Wu, Tao
AU  - Wu T
AD  - Department of Urology, The Affiliated Hospital of Zunyi Medical University, 
      Zunyi, Guizhou 563000, P.R. China.
LA  - eng
PT  - Case Reports
DEP - 20231121
PL  - Greece
TA  - Oncol Lett
JT  - Oncology letters
JID - 101531236
PMC - PMC10698840
OTO - NOTNLM
OT  - Xp11.2
OT  - case report
OT  - fluorescence in situ hybridization
OT  - renal cell carcinoma
OT  - transcription factor E3 gene fusion
COIS- The authors declare that they have no competing interests.
EDAT- 2023/12/11 06:45
MHDA- 2023/12/11 06:46
PMCR- 2023/11/21
CRDT- 2023/12/11 05:35
PHST- 2023/08/30 00:00 [received]
PHST- 2023/10/18 00:00 [accepted]
PHST- 2023/12/11 06:46 [medline]
PHST- 2023/12/11 06:45 [pubmed]
PHST- 2023/12/11 05:35 [entrez]
PHST- 2023/11/21 00:00 [pmc-release]
AID - OL-27-1-14162 [pii]
AID - 10.3892/ol.2023.14162 [doi]
PST - epublish
SO  - Oncol Lett. 2023 Nov 21;27(1):29. doi: 10.3892/ol.2023.14162. eCollection 2024 
      Jan.